Q32 Bio Inc.
QTTB
$1.66
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -97.49% | -26.50% | |||
| Gross Profit | 97.49% | 26.50% | |||
| SG&A Expenses | 28.21% | -10.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.18% | -22.79% | |||
| Operating Income | 22.18% | 22.79% | |||
| Income Before Tax | 30.15% | 10.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.26% | 19.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.26% | 19.36% | |||
| EBIT | 22.18% | 22.79% | |||
| EBITDA | 22.36% | 22.93% | |||
| EPS Basic | 22.36% | 20.05% | |||
| Normalized Basic EPS | 68.48% | -86.07% | |||
| EPS Diluted | 22.36% | 20.21% | |||
| Normalized Diluted EPS | 68.48% | -86.07% | |||
| Average Basic Shares Outstanding | 0.14% | 0.86% | |||
| Average Diluted Shares Outstanding | 0.14% | 0.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||